…on of glucagon-like peptide-1 receptor (GLP-1) agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) needs to…
SEmaglutide
This drug is selected. Its supporting articles are shown below.
Articles mentioning SEmaglutide
69 articles · page 6 of 6…As the use of GLP-1 agonists such as semaglutide and tirzepatide for weight loss becomes increasingly common in …
…ed to a 4-fold reduction with the single GLP-1 receptor agonist semaglutide. Remarkably, the anti-tumor effects of RETA persisted after tre…
…The cardiovascular benefits of weight loss drug semaglutide (Ozempic, Wegovy) occur regardless of how much weight a person …
…M, Bugianesi E, Rinella ME, Roden M, Ratziu V. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis. New Englan…
…re-placebo-controlled study evaluating once-weekly subcutaneous semaglutide in patients with biopsy-confirmed metabolic-dysfunction-associa…
…This article responds to Ryan’s and Savulescu’s claim that semaglutide enhances autonomy by reducing problematic desires. Drawing on F…
… Food and Drug Administration has approved the weight loss drug semaglutide, marketed as Wegovy, for the treatment of patients with a sever…
…ted the true neuroprotective effects of GLP-1 RAs compared with metformin. This underscores the potential superiority of GLP-1 RAs and hi…